KemPharm stock: buy or sell?

KMPH stock price: $0.21 -8.70% At close on May 14th, 2020

Updated on:
May 14th, 2020

1

KemPharm shares collapsed -8.70% to $0.21 today. On May/12 KMPH climbed an outstanding 10.34%.

KemPharm, Inc., a clinical-stage specialty pharmaceutical company, discovers and develops new proprietary prodrugs in the United States.

Should I buy KemPharm stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to define your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, KemPharm stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is KemPharm stock a buy?

Banks and financial institutions publish stock ratings everyday. Unfortunately, we couldn't detect any rating for KMPH stock for the last 30 days.

KemPharm stock analysis

Daily outlook

KemPharm collapsed a bloodcurdling -8.70% and closed at $0.21.

KemPharm shares collapsed -8.70% to $0.21 today. From a daily outlook perspective, KMPH is drawing an uptrend of rising tops and rising bottoms. Since its last top on May 4th at $0.36, price slid and found support around $0.24. Breaking down under $0.24 would cancel the current uptrend and it might slide further to test lower supports. Note that $0.36 might act as a resistance line. If KemPharm breakouts over $0.36 with average or higher volume, this would be a signal that the uptrend resumes.

KMPH stock chart (daily)

Weekly outlook

KemPharm shares plunged -22.22% this week, ending at $0.21. Late April KMPH rocketed a super good 18.75% in just one week.

The downtrend marked by KMPH has left successive falling tops and bottoms. There is an opportunity to rebound and reverse this situation if price can hold above the level. Since price and 20-weeks moving average lines crossed down by mid January, KMPH fell $-0.54 per share (-72.00%).

KMPH stock chart (weekly)

KemPharm stock price history

KemPharm stock went public on April 16th, 2015 with a price of $11.751. Since then, KMPH stock declined a -98.20%, with a yearly average of -19.60%.

1: Adjusted price after possible price splits or reverse-splits.

KemPharm stock historical price chart

KMPH stock reached 52-week highs on June at $2.00, and all-time highs 2015-08-14 with a price of 26.15.

KemPharm stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not detected any price target for KemPharm stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

KemPharm failed analysts when it posted an Earnings per Share (EPS) of $-0.20 when the analysts' forecast was $-0.48.
KMPH earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-1.11n/a
2017-Q2-n/a-0.44n/a
2017-Q32017-11-09-0.67-0.68n/a
2017-Q42018-03-29-0.71-0.72n/a
2018-Q12018-05-10-0.7-1.11n/a
2018-Q22018-08-09-0.98-0.91n/a
2018-Q32018-11-08-0.74-0.94n/a
2018-Q42019-02-28-0.48-0.2n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In , KemPharm annual sales to M dollars from marked in . , its profit margin (compared to revenues) to , that is million.

KMPH annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter income marked $-5.18 M with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, KemPharm sales marked a neutral movement and stayed stable a nan%. Looking back to recent quarterly results, KemPharm posted 7 positive quarters in a row.
KMPH quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

KemPharm ownership

Reviewing KemPharm ownership structure gives valuable information about the company and its governance (insider ownership) or the amount of investors that are on the short side.

KemPharm shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 8.46% of all shares.

In case of KemPharm stock, 14.76% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for KMPH stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related companies:

KMPH
Market cap$12.0 M
Total shares57.4 M
Float shares42.8 M
  - Institutional holdings (%)14.8%
  - Insider holdings (%)8.5%
Shares in short selling0.0%

KemPharm summary

Thursday, May 14th, 2020
Open$0.22
Close$0.21
Day range$0.20 - $0.22
Previous close$0.23
Session gain-8.70%
Average true range$0.04
50d mov avg$0.25
100d mov avg$0.32
200d mov avg$0.51
Daily patternlb03a
Weekly pattern lt02a

KemPharm performance

To measure stock performance is always good to benchmark with competitors or related stocks. We selected as the bechmarking frame for KemPharm stock.
Stock3m6m12m
KMPHKemPharm-40.00%-60.38%-84.21%

KemPharm competitors

Unfortunately, we could not find any public company that could be defined as KemPharm competitor. This doesn't mean KemPharm does not have any competitor in the market, it's just we could not detected it.